Wolverine Trading
ICPT

Wolverine Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wolverine Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,300
Closed -$238K – 5289
2023
Q2 		$238K Buy
+21,300
New +$297K ﹤0.01% 3342
2022
Q4 		– Sell
-35,700
Closed -$586K – 5331
2022
Q3 		$586K Buy
35,700
+22,700
+175% +$366K ﹤0.01% 2477
2022
Q2 		$178K Sell
13,000
-5,700
-30% -$91.3K ﹤0.01% 3612
2022
Q1 		$304K Sell
18,700
-13,400
-42% -$210K ﹤0.01% 3870
2021
Q4 		$524K Sell
32,100
-9,800
-23% -$165K ﹤0.01% 3396
2021
Q3 		$636K Buy
41,900
+16,200
+63% +$259K ﹤0.01% 3596
2021
Q2 		$542K Buy
25,700
+9,800
+62% +$194K ﹤0.01% 3579
2021
Q1 		$360K Sell
15,900
-18,500
-54% -$516K ﹤0.01% 4201
2020
Q4 		$880K Buy
34,400
+4,800
+16% +$159K ﹤0.01% 2526
2020
Q3 		$1.24M Sell
29,600
-2,500
-8% -$115K ﹤0.01% 1862
2020
Q2 		$1.5M Sell
32,100
-700
-2% -$54.1K ﹤0.01% 1625
2020
Q1 		$2.13M Sell
32,800
-55,600
-63% -$5M 0.01% 1289
2019
Q4 		$10.9M Buy
88,400
+28,600
+48% +$2.56M 0.03% 640
2019
Q3 		$3.83M Buy
59,800
+16,400
+38% +$1.1M 0.01% 1015
2019
Q2 		$3.45M Sell
43,400
-26,600
-38% -$2.38M 0.01% 1146
2019
Q1 		$7.83M Sell
70,000
-17,200
-20% -$1.88M 0.02% 624
2018
Q4 		$8.2M Sell
87,200
-10,200
-10% -$1.06M 0.02% 559
2018
Q3 		$12.3M Buy
97,400
+59,700
+158% +$6.32M 0.03% 471
2018
Q2 		$2.32M Hold
37,700
– – 0.01% 1473
2018
Q1 		$2.32M Buy
+37,700
New +$2.27M 0.01% 1473
2017
Q3 		– Sell
-51,600
Closed -$6.33M – 5221
2017
Q2 		$6.33M Buy
51,600
+16,900
+49% +$1.96M 0.03% 562
2017
Q1 		$3.92M Sell
34,700
-46,900
-57% -$5.48M 0.02% 769
2016
Q4 		$8.87M Buy
81,600
+1,300
+2% +$155K 0.04% 440
2016
Q3 		$12.9M Buy
80,300
+18,400
+30% +$2.9M 0.06% 365
2016
Q2 		$9.28M Buy
+61,900
New +$9.03M 0.05% 375

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Wolverine Trading's ICPT Position: Q2 2023 in Review

Wolverine Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 10,482 shares — an estimated $146K sold.

Wolverine Trading first reported a position in ICPT in Q1 2017 and held it in 14 quarters. The position peaked at $4.73M in Q1 2019. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Wolverine Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 10,482 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $146K.
  • Wolverine Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 14 quarters.
  • Wolverine Trading's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.